Arvind SmartSpaces Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: November 3, 2025, 8:11 pm

Competitors of Arvind SmartSpaces Ltd

All Competitor Stocks of Arvind SmartSpaces Ltd

Quarterly Result

Last Updated: August 2, 2025, 12:05 am

Below is a detailed analysis of the quarterly data for Arvind SmartSpaces Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 102.00 Cr.. The value appears to be declining and may need further review. It has decreased from 163.00 Cr. (Mar 2025) to 102.00 Cr., marking a decrease of 61.00 Cr..
• For Expenses, as of Jun 2025, the value is 80.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 130.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 50.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 21.00 Cr.. The value appears to be declining and may need further review. It has decreased from 34.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 13.00 Cr..
• For OPM %, as of Jun 2025, the value is 21.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 21.00%.
• For Other Income, as of Jun 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 11.00 Cr. (Mar 2025) to 5.00 Cr., marking a decrease of 6.00 Cr..
• For Interest, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
• For Depreciation, as of Jun 2025, the value is 2.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.00 Cr. (Mar 2025) to 2.00 Cr., marking an increase of 1.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 17.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 17.00 Cr., marking a decrease of 19.00 Cr..
• For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 39.00% (Mar 2025) to 28.00%, marking a decrease of 11.00%.
• For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 10.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 2.44. The value appears to be declining and may need further review. It has decreased from 4.20 (Mar 2025) to 2.44, marking a decrease of 1.76.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: October 15, 2025, 5:41 am

Growth

Last Updated: September 4, 2025, 11:40 pm

Balance Sheet

Last Updated: July 25, 2025, 3:35 pm

Below is a detailed analysis of the balance sheet data for Arvind SmartSpaces Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 45.00 Cr. (Mar 2024) to 46.00 Cr., marking an increase of 1.00 Cr..
• For Reserves, as of Mar 2025, the value is 552.00 Cr.. The value appears strong and on an upward trend. It has increased from 449.00 Cr. (Mar 2024) to 552.00 Cr., marking an increase of 103.00 Cr..
• For Borrowings, as of Mar 2025, the value is 285.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 110.00 Cr. (Mar 2024) to 285.00 Cr., marking an increase of 175.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 1,783.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,497.00 Cr. (Mar 2024) to 1,783.00 Cr., marking an increase of 286.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 2,666.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,102.00 Cr. (Mar 2024) to 2,666.00 Cr., marking an increase of 564.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 5.00 Cr..
• For CWIP, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 19.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 6.00 Cr..
• For Investments, as of Mar 2025, the value is 186.00 Cr.. The value appears strong and on an upward trend. It has increased from 103.00 Cr. (Mar 2024) to 186.00 Cr., marking an increase of 83.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,397.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,927.00 Cr. (Mar 2024) to 2,397.00 Cr., marking an increase of 470.00 Cr..
• For Total Assets, as of Mar 2025, the value is 2,666.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,102.00 Cr. (Mar 2024) to 2,666.00 Cr., marking an increase of 564.00 Cr..

Notably, the Reserves (552.00 Cr.) exceed the Borrowings (285.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Arvind SmartSpaces Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 24.28. This value is within the healthy range. It has increased from 9.17 (Mar 24) to 24.28, marking an increase of 15.11.
• For Diluted EPS (Rs.), as of Mar 25, the value is 24.00. This value is within the healthy range. It has increased from 9.09 (Mar 24) to 24.00, marking an increase of 14.91.
• For Cash EPS (Rs.), as of Mar 25, the value is 27.24. This value is within the healthy range. It has increased from 12.26 (Mar 24) to 27.24, marking an increase of 14.98.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.24. It has decreased from 138.09 (Mar 24) to 131.24, marking a decrease of 6.85.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 131.24. It has decreased from 138.09 (Mar 24) to 131.24, marking a decrease of 6.85.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 156.55. It has increased from 75.24 (Mar 24) to 156.55, marking an increase of 81.31.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 41.91. This value is within the healthy range. It has increased from 26.72 (Mar 24) to 41.91, marking an increase of 15.19.
• For PBIT / Share (Rs.), as of Mar 25, the value is 40.84. This value is within the healthy range. It has increased from 25.73 (Mar 24) to 40.84, marking an increase of 15.11.
• For PBT / Share (Rs.), as of Mar 25, the value is 36.27. This value is within the healthy range. It has increased from 16.70 (Mar 24) to 36.27, marking an increase of 19.57.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 26.16. This value is within the healthy range. It has increased from 11.27 (Mar 24) to 26.16, marking an increase of 14.89.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 24.25. This value is within the healthy range. It has increased from 9.17 (Mar 24) to 24.25, marking an increase of 15.08.
• For PBDIT Margin (%), as of Mar 25, the value is 26.77. This value is within the healthy range. It has decreased from 35.51 (Mar 24) to 26.77, marking a decrease of 8.74.
• For PBIT Margin (%), as of Mar 25, the value is 26.08. This value exceeds the healthy maximum of 20. It has decreased from 34.19 (Mar 24) to 26.08, marking a decrease of 8.11.
• For PBT Margin (%), as of Mar 25, the value is 23.16. This value is within the healthy range. It has increased from 22.19 (Mar 24) to 23.16, marking an increase of 0.97.
• For Net Profit Margin (%), as of Mar 25, the value is 16.70. This value exceeds the healthy maximum of 10. It has increased from 14.97 (Mar 24) to 16.70, marking an increase of 1.73.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 15.49. This value is within the healthy range. It has increased from 12.18 (Mar 24) to 15.49, marking an increase of 3.31.
• For Return on Networth / Equity (%), as of Mar 25, the value is 18.47. This value is within the healthy range. It has increased from 6.63 (Mar 24) to 18.47, marking an increase of 11.84.
• For Return on Capital Employeed (%), as of Mar 25, the value is 17.71. This value is within the healthy range. It has increased from 16.08 (Mar 24) to 17.71, marking an increase of 1.63.
• For Return On Assets (%), as of Mar 25, the value is 4.13. This value is below the healthy minimum of 5. It has increased from 1.97 (Mar 24) to 4.13, marking an increase of 2.16.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.37. This value is within the healthy range. It has increased from 0.14 (Mar 24) to 0.37, marking an increase of 0.23.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.46. This value is within the healthy range. It has increased from 0.17 (Mar 24) to 0.46, marking an increase of 0.29.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.29. It has increased from 0.18 (Mar 24) to 0.29, marking an increase of 0.11.
• For Current Ratio (X), as of Mar 25, the value is 1.22. This value is below the healthy minimum of 1.5. It has decreased from 1.24 (Mar 24) to 1.22, marking a decrease of 0.02.
• For Quick Ratio (X), as of Mar 25, the value is 0.29. This value is below the healthy minimum of 1. It has increased from 0.25 (Mar 24) to 0.29, marking an increase of 0.04.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.50. This value is below the healthy minimum of 4. It has increased from 0.00 (Mar 24) to 0.50, marking an increase of 0.50.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.40. This value is below the healthy minimum of 20. It has decreased from 35.97 (Mar 24) to 14.40, marking a decrease of 21.57.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 13.78. This value is below the healthy minimum of 20. It has decreased from 32.45 (Mar 24) to 13.78, marking a decrease of 18.67.
• For Earning Retention Ratio (%), as of Mar 25, the value is 85.60. This value exceeds the healthy maximum of 70. It has increased from 64.03 (Mar 24) to 85.60, marking an increase of 21.57.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 86.22. This value exceeds the healthy maximum of 70. It has increased from 67.55 (Mar 24) to 86.22, marking an increase of 18.67.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.18. This value is within the healthy range. It has increased from 2.96 (Mar 24) to 9.18, marking an increase of 6.22.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 6.73. This value is within the healthy range. It has increased from 2.25 (Mar 24) to 6.73, marking an increase of 4.48.
• For Enterprise Value (Cr.), as of Mar 25, the value is 3,647.47. It has increased from 3,204.31 (Mar 24) to 3,647.47, marking an increase of 443.16.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 5.11. This value exceeds the healthy maximum of 3. It has decreased from 9.39 (Mar 24) to 5.11, marking a decrease of 4.28.
• For EV / EBITDA (X), as of Mar 25, the value is 19.10. This value exceeds the healthy maximum of 15. It has decreased from 26.45 (Mar 24) to 19.10, marking a decrease of 7.35.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.51. This value exceeds the healthy maximum of 3. It has decreased from 9.26 (Mar 24) to 4.51, marking a decrease of 4.75.
• For Retention Ratios (%), as of Mar 25, the value is 85.59. This value exceeds the healthy maximum of 70. It has increased from 64.02 (Mar 24) to 85.59, marking an increase of 21.57.
• For Price / BV (X), as of Mar 25, the value is 5.38. This value exceeds the healthy maximum of 3. It has increased from 5.05 (Mar 24) to 5.38, marking an increase of 0.33.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.51. This value exceeds the healthy maximum of 3. It has decreased from 9.26 (Mar 24) to 4.51, marking a decrease of 4.75.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness